InvestorsHub Logo
icon url

Endofanera

02/19/16 1:23 PM

#32464 RE: Bristol19 #32462

Nothing poorly reflecting on TRXC was really mentioned in that article. Thought it would have more substantial info but it wasted my time. Safestitch/TRXC made some silly decisions in the past with reverse mergers and splits that killed the PPS, but all the directors/management they are referencing and their previous companies that didn't do well is how the game is played - Welcome to the world of Biotech, more so early-stage biotech. It's a gamble.

The article didn't' mention the successful companies that those people worked for and previously launched. A similar article could be written about TITXF here in a few years depending on how things go even though the outlook for us looks bright now. Just something to ground you all in how unpredictable this industry can be. There's also a time and place for a company to go public, a majority that I think should stay private longer (TITXF included).
icon url

Flenderson

02/19/16 2:26 PM

#32472 RE: Bristol19 #32462

The one thing I will give credit to Titan management for is they are not frauds. They may be financially challenged, but not frauds. They have expressed to me a couple times about doing everything by the book. Last conversation he went out of his way to make a point about this, including dealings with the FDA and other entities. Looking back, it makes me wonder if they knew something, or had suspicions about the other company.

Someone asked about taking on debt. I actually agree that this wouldn't be a bad idea at this late stage of the game (wouldn't be for it early in the process). Don't think Titan will consider it. Specifically asked them about this and they said going to the markets and raising funds (i.e offerings) is just the best option for development companies.

GLTA